Models and methods: a perspective of the impact of six IMI translational data-centric initiatives for Alzheimer’s disease and other neuropsychiatric disorders

The Innovative Medicines Initiative (IMI), was a European public–private partnership (PPP) undertaking intended to improve the drug development process, facilitate biomarker development, accelerate clinical trial timelines, improve success rates, and generally increase the competitiveness of Europea...

Descripción completa

Detalles Bibliográficos
Autores principales: North, Hilary, Hofmann-Apitius, Martin, Kas, Martien J. H., Marston, Hugh, Haas, Magali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374208/
https://www.ncbi.nlm.nih.gov/pubmed/37521302
http://dx.doi.org/10.3389/fneur.2023.1174079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374208/
https://www.ncbi.nlm.nih.gov/pubmed/37521302
http://dx.doi.org/10.3389/fneur.2023.1174079

Ejemplares similares